More about
Sun Yat-Sen University Cancer Center
News
August 12, 2020
4 min read
Save
Sintilimab plus pemetrexed, chemotherapy extends PFS in non-small cell lung cancer subset
The addition of sintilimab to pemetrexed and platinum chemotherapy conferred a significant PFS benefit for a subset of patients with nonsquamous non-small cell lung cancer, according to results of an interim analysis of the ORIENT-11 study.